Landmark SINGLE-AF Trial Shows Newer Blood Thinners Significantly Lower Stroke Risks for Atrial Fibrillation Patients at Intermediate Risk
A large and rigorous randomized clinical trial has delivered compelling evidence that newer classes of blood-thinning medications can substantially reduce serious cardiovascular complications for individuals living with atrial fibrillation who…